期刊文献+

艾迪注射液联合同步放化疗治疗中晚期软组织肉瘤及对患者VEGF水平的影响 被引量:7

Addie Injection Combined with Concurrent Chemoradiotherapy in Treatment of Advanced Soft Tissue Sarcoma and Its Effect on the Level of VEGF
原文传递
导出
摘要 目的观察艾迪注射液联合同步放化疗治疗中晚期软组织肉瘤及对患者血清中VEGF水平的影响。方法选取我院接收诊治为软组织肉瘤的患者40例分为两组,其中对照组采取放化疗治疗方案进行治疗,研究组在对照组的基础上采取艾迪注射液联合进行治疗,比较两组患者近期的临床治疗效果、患者治疗前后VEGF水平变化情况以及患者预后生活质量的变化情况。结果治疗后,研究组的总缓解率显著高于对照组,两组差异具有可比性(<0.05);两组血清VEGF水平均有明显下降,研究组下降程度明显高于对照组(<0.05);两组生活质量均有改善,研究组社会功能、躯体功能、角色功能、认知功能优于对照组(<0.05);研究组疼痛评分明显低于对照组,两组差异有可比性(<0.05)。结论艾迪注射液联合同步放化方案在治疗软组织肉瘤患者后有较好的疗效,能够有效地降低患者血清中VEGF水平以及提高患者生活质量,值得推广使用。 Objective To observe the effect of Addie injection combined with concurrent chemoradiotherapy in treatment of advanced soft tissue sarcoma and the level of VEGF in serum. Methods 40 cases of patients with soft tissue sarcoma were randomly divided into observation group and control group,20 cases in each group;control group received chemotherapy treatment,observation group received Addie injection on the basis of control group,the recent VEGF changes and changes in the quality of life of patients prognosis were compared before and after treatment. Results The total remission rate in observation group was significantly higher than that of control group,the difference was significant(P〈0.05);serum VEGF levels in both groups were significantly decreased,observation group decreased significantly obviously than that of control group(P〈0.05);The quality of life in both groups was improved after treatment. The social function,body function,role function and cognitive function of the study group were better than the control group(P〈0.05).The VAS score of observation group was significantly lower than that of control group after a period of treatment,and the difference was comparable in the two groups(P〈0.05).Conclusion Addie injection combined with synchronous radiotherapy has better efficiency in treatment of soft tissue sarcoma.It can effectively reduce the level of VEGF in serum and enhance the quality of life of patients. It is worth popularizing.
作者 范晓杰 冯建刚 蒋怡芳 霍炳杰 张子博 FAN Xiaojie;FENG Jian'gang;JIANG Yifang;HUO Bingjie;ZHANG Zibo(Department of Orthopedics,The Fourth Hospital of Hebei Medical University,Shijiazhuang 050011)
出处 《湖北中医药大学学报》 2018年第4期38-41,共4页 Journal of Hubei University of Chinese Medicine
基金 河北省中医药管理局科研计划项目(项目编号:2018141)
关键词 软组织肉瘤 中晚期 艾迪注射液 同步放化疗治疗 VEGF水平 soft tissue sarcoma middle and advanced stage Addie injection concurrent chemoradiotherapy VEGF level
  • 相关文献

参考文献9

二级参考文献129

  • 1杨峥,王旸,余杰,张森,刘瀚文.老年食管癌特征及放化疗结合与单纯放疗的疗效及安全性[J].中国老年学杂志,2014,34(3):778-779. 被引量:19
  • 2赫捷.关于《原发性肺癌诊断标准》的几点说明和体会[J].中国卫生标准管理,2010,1(4):31-32. 被引量:19
  • 3孙燕 周际昌.临床肿瘤内科手册[M].北京:人民卫生出版社,2003.586-591.
  • 4周际吕.实用肿瘤内科学[M].北京:人民卫生出版社.2005:45-46.
  • 5Bareschino MA, Schettino C, Rossi A, et al. Treatment of advanced non small cell lung cancer[ J]. J Thorac Dis,2012,3 (2) :122.
  • 6Kathleen N, Fenton J, David R, et al. Diagnosis and management of ma- lignant pleural effusions [ J ]. Am J Surg,2000 (170) :69 - 74.
  • 7Arias JL. Drug targeting strategies in cancer treatment., an overview [J]. Mini RevMed Chem,2011,11(1):l.
  • 8Thippeswamy R,Noronha V,Krishna V,et al. Stage IVlung cancer:is cure possible [ J ]. Indian J Med Paediatr Onco1,2013,34 ( 2 ) : 121 - 125.
  • 9Zarogoulidis K, Zarogoulidis P, Darwiche K, et al. Malignant pleural effusion and algorithm management [ J ]. J Thorac Dis, 2013,5 (4) : $412 - $419.
  • 10BastiaannetE, GroenH, JagerPL, et al. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis[J]. Cancer Treat Rev, 2004, 30(1):83-101. DOI:10.1016/j.ctrv.2003.07.004.

共引文献127

同被引文献91

引证文献7

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部